Ascendis Health secures R350m antibiotics tender

Dr Karsten Wellner (Supplied)
Dr Karsten Wellner (Supplied)

Johannesburg - Ascendis Health's Pharma division has been awarded a R350m state antibiotics tender.
 
The products will be distributed over a two year period. The tender covers specialist first generation molecules which are first line treatments used by the state to combat infections.
 
Ascendis will commence distribution towards the end of November 2015 in tandem with a national education programme regarding antibiotic stewardship. The programme is aimed at healthcare practitioners at government hospitals and clinics and will reinforce the judicial use of antibiotics to combat resistance.  

The tender award will also allow economies of scale for the same products into the dispensing doctors market and allow Ascendis Health to further focus on accessibility and affordability of its generic products.
 
Dr Karsten Wellner, CEO of Ascendis Health, said the tender, as is a clear indication of the success of the group's integration strategies by unlocking value across the production and supply chain, allowing it to offer a growing range of products at competitive pricing.
 
The announcement follows hot on the heels of the acquisition by Ascendis of Spanish pharmaceutical group Famalider who specialises in the development and manufacture of generic pharmaceuticals, as well as the acquisition of 85 already MCC registered generics, that are currently not marketed, from Sandoz South Africa.

ZAR/USD
16.58
(+0.81)
ZAR/GBP
21.38
(+1.02)
ZAR/EUR
19.48
(+0.61)
ZAR/AUD
11.93
(+0.39)
ZAR/JPY
0.16
(+0.85)
Gold
1905.79
(+0.95)
Silver
23.81
(+1.98)
Platinum
897.00
(+0.75)
Brent Crude
42.12
(+1.78)
Palladium
2312.00
(+0.85)
All Share
54446.78
(+0.34)
Top 40
50159.14
(+0.23)
Financial 15
10158.72
(+0.86)
Industrial 25
73766.43
(+0.79)
Resource 10
53032.08
(-0.66)
All JSE data delayed by at least 15 minutes morningstar logo
Company Snapshot
Voting Booth
Do you think it was a good idea for the government to approach the IMF for a $4.3 billion loan to fight Covid-19?
Please select an option Oops! Something went wrong, please try again later.
Results
Yes. We need the money.
11% - 1404 votes
It depends on how the funds are used.
73% - 9095 votes
No. We should have gotten the loan elsewhere.
16% - 2000 votes
Vote